Division News

Thomas LeBlanc, MD, assistant professor of medicine (Hematological Malignancies and Cellular Therapy), is one of 10 recipients of a two-year, $180,000 grant from the Cambia Health Foundation through its annual Sojourns Scholar Leadership Program.

Stefanie Sarantopoulos, MD, PhD, associate professor of medicine (Hematological Malignancies and Cellular Therapy) has received notice of her first R01 award from NIH to to determine mechanisms that drive or suppress pathological B cells after hematopoietic cell transplantation, so that targeted and preventative therapies can be effectively devised.

Internationally recognized for its novel approaches to treating leukemia, lymphoma and multiple myeloma, the Duke Cancer Institutes’s Adult Bone Marrow Transplant (ABMT) Program celebrates its 30th anniversary in June 2015. The program, which performs about 300 transplants annually, is expected to have administered its 5,000th transplant by the end of June.

Three of the nation’s largest philanthropies – the Howard Hughes Medical Institute, the Bill & Melinda Gates Foundation, and the Simons Foundation – have announced a new partnership to provide much needed research support to outstanding early-career scientists in the United States.

Through the new Faculty Scholars Program, the philanthropies will invest a total of $148 million in research support over the program’s first five years.

The Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services, awarded Duke University researchers who are developing a blood test that can tell in just hours how much radiation a person has absorbed from a nuclear incident an additional $10.4 million contract to continue the program through early 2016, bringing total funding since 2009 to more than $43 million.